 | • レポートコード：MRC2-11QY09131 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はリファンピシンのグローバル市場について調査・分析したレポートです。種類別（経口、静脈内注射）市場規模、用途別（結核、ハンセン病、レジオネラ症、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別リファンピシンの競争状況、市場シェア ・世界のリファンピシン市場：種類別市場規模 2015年-2020年（経口、静脈内注射） ・世界のリファンピシン市場：種類別市場規模予測 2021年-2026年（経口、静脈内注射） ・世界のリファンピシン市場：用途別市場規模 2015年-2020年（結核、ハンセン病、レジオネラ症、その他） ・世界のリファンピシン市場：用途別市場規模予測 2021年-2026年（結核、ハンセン病、レジオネラ症、その他） ・北米のリファンピシン市場分析：米国、カナダ ・ヨーロッパのリファンピシン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのリファンピシン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のリファンピシン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのリファンピシン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Sanofi、Wellona Pharma、AVANSCURE LIFESCIENCES、Hebei Xingang Pharmaceutical、Mercator Pharmaceutical Solutions、ASIAN PHARMACY、A. S. JOSHI & COMPANY ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Rifampicin, also known as rifampin, is an antibiotic used to treat several types of bacterial infections, including tuberculosis, mycobacterium avium complex, leprosy, and Legionnaire’s disease. Common side effects include nausea, vomiting, diarrhea, and loss of appetite.
Market Analysis and Insights: Global Rifampicin Market
The global Rifampicin market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Rifampicin Scope and Market Size
Rifampicin market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Rifampicin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Rifampicin market is segmented into
Oral
Intravenous Injection
Segment by Application, the Rifampicin market is segmented into
Tuberculosis
Leprosy
Legionnaire’s Disease
Others
Regional and Country-level Analysis
The Rifampicin market is analysed and market size information is provided by regions (countries).
The key regions covered in the Rifampicin market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Rifampicin Market Share Analysis
Rifampicin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Rifampicin business, the date to enter into the Rifampicin market, Rifampicin product introduction, recent developments, etc.
The major vendors covered:
Sanofi
Wellona Pharma
AVANSCURE LIFESCIENCES
Hebei Xingang Pharmaceutical
Mercator Pharmaceutical Solutions
ASIAN PHARMACY
A. S. JOSHI & COMPANY
…
1 Study Coverage
1.1 Rifampicin Product Introduction
1.2 Market Segments
1.3 Key Rifampicin Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Rifampicin Market Size Growth Rate by Type
1.4.2 Oral
1.4.3 Intravenous Injection
1.5 Market by Application
1.5.1 Global Rifampicin Market Size Growth Rate by Application
1.5.2 Tuberculosis
1.5.3 Leprosy
1.5.4 Legionnaire’s Disease
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Rifampicin Market Size, Estimates and Forecasts
2.1.1 Global Rifampicin Revenue 2015-2026
2.1.2 Global Rifampicin Sales 2015-2026
2.2 Global Rifampicin, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Rifampicin Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Rifampicin Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Rifampicin Competitor Landscape by Players
3.1 Rifampicin Sales by Manufacturers
3.1.1 Rifampicin Sales by Manufacturers (2015-2020)
3.1.2 Rifampicin Sales Market Share by Manufacturers (2015-2020)
3.2 Rifampicin Revenue by Manufacturers
3.2.1 Rifampicin Revenue by Manufacturers (2015-2020)
3.2.2 Rifampicin Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Rifampicin Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Rifampicin Revenue in 2019
3.2.5 Global Rifampicin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Rifampicin Price by Manufacturers
3.4 Rifampicin Manufacturing Base Distribution, Product Types
3.4.1 Rifampicin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Rifampicin Product Type
3.4.3 Date of International Manufacturers Enter into Rifampicin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Rifampicin Market Size by Type (2015-2020)
4.1.1 Global Rifampicin Sales by Type (2015-2020)
4.1.2 Global Rifampicin Revenue by Type (2015-2020)
4.1.3 Rifampicin Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Rifampicin Market Size Forecast by Type (2021-2026)
4.2.1 Global Rifampicin Sales Forecast by Type (2021-2026)
4.2.2 Global Rifampicin Revenue Forecast by Type (2021-2026)
4.2.3 Rifampicin Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Rifampicin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Rifampicin Market Size by Application (2015-2020)
5.1.1 Global Rifampicin Sales by Application (2015-2020)
5.1.2 Global Rifampicin Revenue by Application (2015-2020)
5.1.3 Rifampicin Price by Application (2015-2020)
5.2 Rifampicin Market Size Forecast by Application (2021-2026)
5.2.1 Global Rifampicin Sales Forecast by Application (2021-2026)
5.2.2 Global Rifampicin Revenue Forecast by Application (2021-2026)
5.2.3 Global Rifampicin Price Forecast by Application (2021-2026)
6 North America
6.1 North America Rifampicin by Country
6.1.1 North America Rifampicin Sales by Country
6.1.2 North America Rifampicin Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Rifampicin Market Facts & Figures by Type
6.3 North America Rifampicin Market Facts & Figures by Application
7 Europe
7.1 Europe Rifampicin by Country
7.1.1 Europe Rifampicin Sales by Country
7.1.2 Europe Rifampicin Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Rifampicin Market Facts & Figures by Type
7.3 Europe Rifampicin Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Rifampicin by Region
8.1.1 Asia Pacific Rifampicin Sales by Region
8.1.2 Asia Pacific Rifampicin Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Rifampicin Market Facts & Figures by Type
8.3 Asia Pacific Rifampicin Market Facts & Figures by Application
9 Latin America
9.1 Latin America Rifampicin by Country
9.1.1 Latin America Rifampicin Sales by Country
9.1.2 Latin America Rifampicin Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Rifampicin Market Facts & Figures by Type
9.3 Central & South America Rifampicin Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Rifampicin by Country
10.1.1 Middle East and Africa Rifampicin Sales by Country
10.1.2 Middle East and Africa Rifampicin Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Rifampicin Market Facts & Figures by Type
10.3 Middle East and Africa Rifampicin Market Facts & Figures by Application
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Description and Business Overview
11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Rifampicin Products Offered
11.1.5 Sanofi Related Developments
11.2 Wellona Pharma
11.2.1 Wellona Pharma Corporation Information
11.2.2 Wellona Pharma Description and Business Overview
11.2.3 Wellona Pharma Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Wellona Pharma Rifampicin Products Offered
11.2.5 Wellona Pharma Related Developments
11.3 AVANSCURE LIFESCIENCES
11.3.1 AVANSCURE LIFESCIENCES Corporation Information
11.3.2 AVANSCURE LIFESCIENCES Description and Business Overview
11.3.3 AVANSCURE LIFESCIENCES Sales, Revenue and Gross Margin (2015-2020)
11.3.4 AVANSCURE LIFESCIENCES Rifampicin Products Offered
11.3.5 AVANSCURE LIFESCIENCES Related Developments
11.4 Hebei Xingang Pharmaceutical
11.4.1 Hebei Xingang Pharmaceutical Corporation Information
11.4.2 Hebei Xingang Pharmaceutical Description and Business Overview
11.4.3 Hebei Xingang Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Hebei Xingang Pharmaceutical Rifampicin Products Offered
11.4.5 Hebei Xingang Pharmaceutical Related Developments
11.5 Mercator Pharmaceutical Solutions
11.5.1 Mercator Pharmaceutical Solutions Corporation Information
11.5.2 Mercator Pharmaceutical Solutions Description and Business Overview
11.5.3 Mercator Pharmaceutical Solutions Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Mercator Pharmaceutical Solutions Rifampicin Products Offered
11.5.5 Mercator Pharmaceutical Solutions Related Developments
11.6 ASIAN PHARMACY
11.6.1 ASIAN PHARMACY Corporation Information
11.6.2 ASIAN PHARMACY Description and Business Overview
11.6.3 ASIAN PHARMACY Sales, Revenue and Gross Margin (2015-2020)
11.6.4 ASIAN PHARMACY Rifampicin Products Offered
11.6.5 ASIAN PHARMACY Related Developments
11.7 A. S. JOSHI & COMPANY
11.7.1 A. S. JOSHI & COMPANY Corporation Information
11.7.2 A. S. JOSHI & COMPANY Description and Business Overview
11.7.3 A. S. JOSHI & COMPANY Sales, Revenue and Gross Margin (2015-2020)
11.7.4 A. S. JOSHI & COMPANY Rifampicin Products Offered
11.7.5 A. S. JOSHI & COMPANY Related Developments
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Description and Business Overview
11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Rifampicin Products Offered
11.1.5 Sanofi Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Rifampicin Market Estimates and Projections by Region
12.1.1 Global Rifampicin Sales Forecast by Regions 2021-2026
12.1.2 Global Rifampicin Revenue Forecast by Regions 2021-2026
12.2 North America Rifampicin Market Size Forecast (2021-2026)
12.2.1 North America: Rifampicin Sales Forecast (2021-2026)
12.2.2 North America: Rifampicin Revenue Forecast (2021-2026)
12.2.3 North America: Rifampicin Market Size Forecast by Country (2021-2026)
12.3 Europe Rifampicin Market Size Forecast (2021-2026)
12.3.1 Europe: Rifampicin Sales Forecast (2021-2026)
12.3.2 Europe: Rifampicin Revenue Forecast (2021-2026)
12.3.3 Europe: Rifampicin Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Rifampicin Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Rifampicin Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Rifampicin Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Rifampicin Market Size Forecast by Region (2021-2026)
12.5 Latin America Rifampicin Market Size Forecast (2021-2026)
12.5.1 Latin America: Rifampicin Sales Forecast (2021-2026)
12.5.2 Latin America: Rifampicin Revenue Forecast (2021-2026)
12.5.3 Latin America: Rifampicin Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Rifampicin Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Rifampicin Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Rifampicin Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Rifampicin Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Rifampicin Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Rifampicin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Rifampicin Market Segments
Table 2. Ranking of Global Top Rifampicin Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Rifampicin Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of Oral
Table 5. Major Manufacturers of Intravenous Injection
Table 6. Global Rifampicin Market Size Growth Rate by Application 2020-2026 (MT)
Table 7. Global Rifampicin Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 8. Global Rifampicin Sales by Regions 2015-2020 (MT)
Table 9. Global Rifampicin Sales Market Share by Regions (2015-2020)
Table 10. Global Rifampicin Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Rifampicin Sales by Manufacturers (2015-2020) (MT)
Table 12. Global Rifampicin Sales Share by Manufacturers (2015-2020)
Table 13. Global Rifampicin Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Rifampicin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rifampicin as of 2019)
Table 15. Rifampicin Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Rifampicin Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Rifampicin Price (2015-2020) (USD/MT)
Table 18. Rifampicin Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Rifampicin Product Type
Table 20. Date of International Manufacturers Enter into Rifampicin Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Rifampicin Sales by Type (2015-2020) (MT)
Table 23. Global Rifampicin Sales Share by Type (2015-2020)
Table 24. Global Rifampicin Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Rifampicin Revenue Share by Type (2015-2020)
Table 26. Rifampicin Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 27. Global Rifampicin Sales by Application (2015-2020) (MT)
Table 28. Global Rifampicin Sales Share by Application (2015-2020)
Table 29. North America Rifampicin Sales by Country (2015-2020) (MT)
Table 30. North America Rifampicin Sales Market Share by Country (2015-2020)
Table 31. North America Rifampicin Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Rifampicin Revenue Market Share by Country (2015-2020)
Table 33. North America Rifampicin Sales by Type (2015-2020) (MT)
Table 34. North America Rifampicin Sales Market Share by Type (2015-2020)
Table 35. North America Rifampicin Sales by Application (2015-2020) (MT)
Table 36. North America Rifampicin Sales Market Share by Application (2015-2020)
Table 37. Europe Rifampicin Sales by Country (2015-2020) (MT)
Table 38. Europe Rifampicin Sales Market Share by Country (2015-2020)
Table 39. Europe Rifampicin Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Rifampicin Revenue Market Share by Country (2015-2020)
Table 41. Europe Rifampicin Sales by Type (2015-2020) (MT)
Table 42. Europe Rifampicin Sales Market Share by Type (2015-2020)
Table 43. Europe Rifampicin Sales by Application (2015-2020) (MT)
Table 44. Europe Rifampicin Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Rifampicin Sales by Region (2015-2020) (MT)
Table 46. Asia Pacific Rifampicin Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Rifampicin Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Rifampicin Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Rifampicin Sales by Type (2015-2020) (MT)
Table 50. Asia Pacific Rifampicin Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Rifampicin Sales by Application (2015-2020) (MT)
Table 52. Asia Pacific Rifampicin Sales Market Share by Application (2015-2020)
Table 53. Latin America Rifampicin Sales by Country (2015-2020) (MT)
Table 54. Latin America Rifampicin Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Rifampicin Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Rifampicin Revenue Market Share by Country (2015-2020)
Table 57. Latin America Rifampicin Sales by Type (2015-2020) (MT)
Table 58. Latin America Rifampicin Sales Market Share by Type (2015-2020)
Table 59. Latin America Rifampicin Sales by Application (2015-2020) (MT)
Table 60. Latin America Rifampicin Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Rifampicin Sales by Country (2015-2020) (MT)
Table 62. Middle East and Africa Rifampicin Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Rifampicin Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Rifampicin Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Rifampicin Sales by Type (2015-2020) (MT)
Table 66. Middle East and Africa Rifampicin Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Rifampicin Sales by Application (2015-2020) (MT)
Table 68. Middle East and Africa Rifampicin Sales Market Share by Application (2015-2020)
Table 69. Sanofi Corporation Information
Table 70. Sanofi Description and Major Businesses
Table 71. Sanofi Rifampicin Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 72. Sanofi Product
Table 73. Sanofi Recent Development
Table 74. Wellona Pharma Corporation Information
Table 75. Wellona Pharma Description and Major Businesses
Table 76. Wellona Pharma Rifampicin Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Wellona Pharma Product
Table 78. Wellona Pharma Recent Development
Table 79. AVANSCURE LIFESCIENCES Corporation Information
Table 80. AVANSCURE LIFESCIENCES Description and Major Businesses
Table 81. AVANSCURE LIFESCIENCES Rifampicin Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. AVANSCURE LIFESCIENCES Product
Table 83. AVANSCURE LIFESCIENCES Recent Development
Table 84. Hebei Xingang Pharmaceutical Corporation Information
Table 85. Hebei Xingang Pharmaceutical Description and Major Businesses
Table 86. Hebei Xingang Pharmaceutical Rifampicin Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Hebei Xingang Pharmaceutical Product
Table 88. Hebei Xingang Pharmaceutical Recent Development
Table 89. Mercator Pharmaceutical Solutions Corporation Information
Table 90. Mercator Pharmaceutical Solutions Description and Major Businesses
Table 91. Mercator Pharmaceutical Solutions Rifampicin Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Mercator Pharmaceutical Solutions Product
Table 93. Mercator Pharmaceutical Solutions Recent Development
Table 94. ASIAN PHARMACY Corporation Information
Table 95. ASIAN PHARMACY Description and Major Businesses
Table 96. ASIAN PHARMACY Rifampicin Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. ASIAN PHARMACY Product
Table 98. ASIAN PHARMACY Recent Development
Table 99. A. S. JOSHI & COMPANY Corporation Information
Table 100. A. S. JOSHI & COMPANY Description and Major Businesses
Table 101. A. S. JOSHI & COMPANY Rifampicin Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. A. S. JOSHI & COMPANY Product
Table 103. A. S. JOSHI & COMPANY Recent Development
Table 104. Global Rifampicin Sales Forecast by Regions (2021-2026) (MT)
Table 105. Global Rifampicin Sales Market Share Forecast by Regions (2021-2026)
Table 106. Global Rifampicin Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 107. Global Rifampicin Revenue Market Share Forecast by Regions (2021-2026)
Table 108. North America: Rifampicin Sales Forecast by Country (2021-2026) (MT)
Table 109. North America: Rifampicin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Europe: Rifampicin Sales Forecast by Country (2021-2026) (MT)
Table 111. Europe: Rifampicin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Asia Pacific: Rifampicin Sales Forecast by Region (2021-2026) (MT)
Table 113. Asia Pacific: Rifampicin Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Latin America: Rifampicin Sales Forecast by Country (2021-2026) (MT)
Table 115. Latin America: Rifampicin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Middle East and Africa: Rifampicin Sales Forecast by Country (2021-2026) (MT)
Table 117. Middle East and Africa: Rifampicin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 119. Key Challenges
Table 120. Market Risks
Table 121. Main Points Interviewed from Key Rifampicin Players
Table 122. Rifampicin Customers List
Table 123. Rifampicin Distributors List
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Rifampicin Product Picture
Figure 2. Global Rifampicin Sales Market Share by Type in 2020 & 2026
Figure 3. Oral Product Picture
Figure 4. Intravenous Injection Product Picture
Figure 5. Global Rifampicin Sales Market Share by Application in 2020 & 2026
Figure 6. Tuberculosis
Figure 7. Leprosy
Figure 8. Legionnaire's Disease
Figure 9. Others
Figure 10. Rifampicin Report Years Considered
Figure 11. Global Rifampicin Market Size 2015-2026 (US$ Million)
Figure 12. Global Rifampicin Sales 2015-2026 (MT)
Figure 13. Global Rifampicin Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Rifampicin Sales Market Share by Region (2015-2020)
Figure 15. Global Rifampicin Sales Market Share by Region in 2019
Figure 16. Global Rifampicin Revenue Market Share by Region (2015-2020)
Figure 17. Global Rifampicin Revenue Market Share by Region in 2019
Figure 18. Global Rifampicin Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Rifampicin Revenue in 2019
Figure 20. Rifampicin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Rifampicin Sales Market Share by Type (2015-2020)
Figure 22. Global Rifampicin Sales Market Share by Type in 2019
Figure 23. Global Rifampicin Revenue Market Share by Type (2015-2020)
Figure 24. Global Rifampicin Revenue Market Share by Type in 2019
Figure 25. Global Rifampicin Market Share by Price Range (2015-2020)
Figure 26. Global Rifampicin Sales Market Share by Application (2015-2020)
Figure 27. Global Rifampicin Sales Market Share by Application in 2019
Figure 28. Global Rifampicin Revenue Market Share by Application (2015-2020)
Figure 29. Global Rifampicin Revenue Market Share by Application in 2019
Figure 30. North America Rifampicin Sales Growth Rate 2015-2020 (MT)
Figure 31. North America Rifampicin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Rifampicin Sales Market Share by Country in 2019
Figure 33. North America Rifampicin Revenue Market Share by Country in 2019
Figure 34. U.S. Rifampicin Sales Growth Rate (2015-2020) (MT)
Figure 35. U.S. Rifampicin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Rifampicin Sales Growth Rate (2015-2020) (MT)
Figure 37. Canada Rifampicin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Rifampicin Market Share by Type in 2019
Figure 39. North America Rifampicin Market Share by Application in 2019
Figure 40. Europe Rifampicin Sales Growth Rate 2015-2020 (MT)
Figure 41. Europe Rifampicin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Rifampicin Sales Market Share by Country in 2019
Figure 43. Europe Rifampicin Revenue Market Share by Country in 2019
Figure 44. Germany Rifampicin Sales Growth Rate (2015-2020) (MT)
Figure 45. Germany Rifampicin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Rifampicin Sales Growth Rate (2015-2020) (MT)
Figure 47. France Rifampicin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Rifampicin Sales Growth Rate (2015-2020) (MT)
Figure 49. U.K. Rifampicin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Rifampicin Sales Growth Rate (2015-2020) (MT)
Figure 51. Italy Rifampicin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Rifampicin Sales Growth Rate (2015-2020) (MT)
Figure 53. Russia Rifampicin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Rifampicin Market Share by Type in 2019
Figure 55. Europe Rifampicin Market Share by Application in 2019
Figure 56. Asia Pacific Rifampicin Sales Growth Rate 2015-2020 (MT)
Figure 57. Asia Pacific Rifampicin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Rifampicin Sales Market Share by Region in 2019
Figure 59. Asia Pacific Rifampicin Revenue Market Share by Region in 2019
Figure 60. China Rifampicin Sales Growth Rate (2015-2020) (MT)
Figure 61. China Rifampicin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Rifampicin Sales Growth Rate (2015-2020) (MT)
Figure 63. Japan Rifampicin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Rifampicin Sales Growth Rate (2015-2020) (MT)
Figure 65. South Korea Rifampicin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Rifampicin Sales Growth Rate (2015-2020) (MT)
Figure 67. India Rifampicin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Rifampicin Sales Growth Rate (2015-2020) (MT)
Figure 69. Australia Rifampicin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Rifampicin Sales Growth Rate (2015-2020) (MT)
Figure 71. Taiwan Rifampicin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Rifampicin Sales Growth Rate (2015-2020) (MT)
Figure 73. Indonesia Rifampicin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Rifampicin Sales Growth Rate (2015-2020) (MT)
Figure 75. Thailand Rifampicin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Rifampicin Sales Growth Rate (2015-2020) (MT)
Figure 77. Malaysia Rifampicin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Rifampicin Sales Growth Rate (2015-2020) (MT)
Figure 79. Philippines Rifampicin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Rifampicin Sales Growth Rate (2015-2020) (MT)
Figure 81. Vietnam Rifampicin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Rifampicin Market Share by Type in 2019
Figure 83. Asia Pacific Rifampicin Market Share by Application in 2019
Figure 84. Latin America Rifampicin Sales Growth Rate 2015-2020 (MT)
Figure 85. Latin America Rifampicin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Rifampicin Sales Market Share by Country in 2019
Figure 87. Latin America Rifampicin Revenue Market Share by Country in 2019
Figure 88. Mexico Rifampicin Sales Growth Rate (2015-2020) (MT)
Figure 89. Mexico Rifampicin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Rifampicin Sales Growth Rate (2015-2020) (MT)
Figure 91. Brazil Rifampicin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Rifampicin Sales Growth Rate (2015-2020) (MT)
Figure 93. Argentina Rifampicin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Rifampicin Market Share by Type in 2019
Figure 95. Latin America Rifampicin Market Share by Application in 2019
Figure 96. Middle East and Africa Rifampicin Sales Growth Rate 2015-2020 (MT)
Figure 97. Middle East and Africa Rifampicin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Rifampicin Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Rifampicin Revenue Market Share by Country in 2019
Figure 100. Turkey Rifampicin Sales Growth Rate (2015-2020) (MT)
Figure 101. Turkey Rifampicin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Rifampicin Sales Growth Rate (2015-2020) (MT)
Figure 103. Saudi Arabia Rifampicin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Rifampicin Sales Growth Rate (2015-2020) (MT)
Figure 105. U.A.E Rifampicin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Rifampicin Market Share by Type in 2019
Figure 107. Middle East and Africa Rifampicin Market Share by Application in 2019
Figure 108. North America Rifampicin Sales Growth Rate Forecast (2021-2026) (MT)
Figure 109. North America Rifampicin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Rifampicin Sales Growth Rate Forecast (2021-2026) (MT)
Figure 111. Europe Rifampicin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Rifampicin Sales Growth Rate Forecast (2021-2026) (MT)
Figure 113. Asia Pacific Rifampicin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Rifampicin Sales Growth Rate Forecast (2021-2026) (MT)
Figure 115. Latin America Rifampicin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Rifampicin Sales Growth Rate Forecast (2021-2026) (MT)
Figure 117. Middle East and Africa Rifampicin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
ハンセン病治療の世界市場（～2026年） Leprosy, also known as Hansen's disease (HD), is a long-term infection by the bacterium Mycobacterium leprae or Mycobacterium lepromatosis. Initially, infections are without symptoms and typically remain this way for 5 to 20 years. Symptoms that develop include granulomas of the nerves, respiratory …- 結核（TB）診断の世界市場（～2026年） Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of lat…
- 結核治療の世界市場（～2026年） Market Analysis and Insights: Global Tuberculosis Treatment Market The global Tuberculosis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Tuberculosis Treatment Scope and Market Size Tuberculosis Treatment m…
- 結核ワクチン治療の世界市場（～2026年） Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB). Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at …
- 抗結核治療薬の世界市場（～2026年） Tuberculosis (TB) is an infectious disease, which is caused by Mycobacterium tuberculosis. These bacteria generally infect human lungs. However, it can infect other body parts/organs as well. Three major types of tuberculosis are found: latent, active, and drug-resistant tuberculosis. Symptoms are n…